FABRICE CHOURAQUI

Fabrice Chouraqui serves as a distinguished Partner at Flagship Pioneering, a unique venture creation firm renowned for its groundbreaking approach to building revolutionary life science companies. In this pivotal role, Mr. Chouraqui is instrumental in Flagship's distinctive model of conceiving, developing, and launching ventures that aim to transform human health and sustainability. His expertise is critical in identifying nascent scientific opportunities, nurturing them into viable companies, and guiding their strategic growth from inception to market leadership.

Mr. Chouraqui's investment focus areas align perfectly with Flagship Pioneering's mission: to create and invest in companies that leverage cutting-edge biological insights and technological innovation to address significant unmet medical needs. This includes pioneering novel therapeutic platforms, advancing precision medicine, developing innovative drug discovery methodologies, and exploring new frontiers in areas like gene therapy, immunology, and oncology. His strategic vision helps shape companies poised to deliver transformative impact across the healthcare landscape.

Before joining Flagship Pioneering, Fabrice Chouraqui built an impressive career marked by significant leadership roles in the global pharmaceutical industry. He previously served as the Chief Executive Officer of Teva Pharmaceuticals International, where he oversaw a vast international business and played a key role in shaping global pharmaceutical strategies. Prior to Teva, Mr. Chouraqui held several senior leadership positions at Sanofi, including Head of Global Pharma Operations, Senior Vice President of Global General Medicines, and Senior Vice President of Asia Pacific. His extensive background in global operations, commercial strategy, and market access provides invaluable insight into the complexities of bringing innovative therapies to patients worldwide. This rich operational experience is a significant asset in guiding Flagship's portfolio companies through their development and commercialization phases.

While Flagship Pioneering's model often involves creating companies from scratch rather than traditional investments, Mr. Chouraqui's involvement contributes to the success of numerous ventures within the Flagship ecosystem. These companies, often incubated within Flagship Labs, aim to develop breakthrough medicines and technologies. His leadership helps ensure these nascent companies are built on solid strategic and operational foundations, positioning them for future success and significant impact in the life sciences sector.